ACST - Acasti Pharma Revenue Dynamics YoY (Last Twelve Months)

Graphic logo of acastipharma.com (ACST)

Acasti Pharma (ACST) monetizes proprietary drug delivery methods to the nervous system, ensuring stable returns. The business relies on an asset-light model, outsourcing production to third-party contractors to generate high-margin royalties. The year-over-year sales trajectory (TTM) on this GURU.Markets chart illustrates the scaling of programs for rare pathologies, while -100.30 is recorded as the baseline value.

ACST Acasti Pharma: Sales Growth YoY (Last Twelve Months) in the range 02/11/2024 - 02/20/2024

Acasti Pharma Inc (ACST) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
- market capitalization statistics:
Summary company analytics:ACST (acastipharma.com)
Mass-produced product of Acasti Pharma Inc.

The development of drugs for rare cardiac diseases is independent of economic cycles; therefore, the stability of Acasti Pharma (ACST) is primarily determined by its internal liquidity reserves. The LTM sales growth YoY metric measures the rate of change in rolling revenue, reflecting the business's ability to maintain market positions, where any deviation from the norm on this chart serves as a signal for a fundamental revaluation of asset costs.